Acute Anaphylaxis Clinical Care Standard: 6c-Proportion of patients treated for anaphylaxis who require adrenaline injectors who are supplied or prescribed an adrenaline injector prior to separation from hospital.
Indicator Attributes
Identifying and definitional attributes | |
Metadata item type: | Indicator |
---|---|
Indicator type: | Indicator |
Short name: | 6c-Proportion of patients treated for anaphylaxis who require adrenaline injectors who are supplied or prescribed an adrenaline injector prior to separation from hospital. |
METEOR identifier: | 745157 |
Registration status: | Australian Commission on Safety and Quality in Health Care, Standard 24/11/2021 |
Description: | Proportion of patients treated for anaphylaxis who require adrenaline injectors who are supplied or prescribed an adrenaline injector prior to separation from hospital. |
Indicator set: |
Collection and usage attributes | |||||||||||
Population group age from: | All ages | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Computation description: | For the numerator and denominator separations involving patients with anaphylaxis in hospital settings can be identified using the ICD codes specified in Table A. Table A: ICD-10-AM 11th edition codes for anaphylaxis
Presented as a percentage. | ||||||||||
Computation: | (Numerator ÷ Denominator) x 100 | ||||||||||
Numerator: | The number of patients treated for anaphylaxis who require adrenaline injectors who are supplied or prescribed an adrenaline injector prior to separation from hospital. | ||||||||||
Denominator: | The number of patients treated for anaphylaxis who require an adrenaline injector. | ||||||||||
Comments: | A patient should be given a personal adrenaline injector or a prescription for this medicine where there is a risk of re-exposure to the allergen. Use of adrenaline injector is typically recommended for patients with:
For a comprehensive list of considerations to identify patients for whom use of adrenalin injectors are appropriate, please refer to the ASCIA Guidelines - Adrenaline (Epinephrine) Autoinjector Prescription. | ||||||||||
Representational attributes | |||||||||||
Representation class: | Percentage | ||||||||||
Data type: | Real | ||||||||||
Unit of measure: | Person | ||||||||||
Format: | N[NN] | ||||||||||
Accountability attributes | |||||||||||
Other issues caveats: | Applicable settings: public and private hospitals. | ||||||||||
Source and reference attributes | |||||||||||
Submitting organisation: | Australian Commission on Safety and Quality in Health Care | ||||||||||
Reference documents: | Australian Commission on Safety and Quality in Health Care 2021. Acute Anaphylaxis clinical care standard. Australian Commission on Safety and Quality in Health Care, Sydney.
|